Pasar al contenido principal

PROTEOMIC AND BIOINFORMATIC STUDIES OF SYNAPTIC FUNCTION IN THE CONTEXT OF HUMAN MENTAL AND BEHAVIOURAL DISORDERS.

RYC-2011-08391

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Contratación e Incorporación de RRHH
Subprograma Subprograma Ramón y Cajal (RYC)
Convocatoria Ramón y Cajal
Año convocatoria 2011
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Formación e Incorporación de Investigadores
Centro beneficiario INSTITUT DE RECERCA DE L HOSPITAL DE LA SANTA CREU I SANT PAU
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Delta9-tetrahydrocannabinol modulates the proteasome system in the brain

  • Salgado Mendialdúa, Victòria
  • Aguirre Plans, Joaquim, 1993-
  • Guney, Emre
  • Reig-Viader, Rita
  • Maldonado, Rafael, 1961-
  • Bayés, Angels
  • Oliva Miguel, Baldomero
  • Ozaita Mintegui, Andrés, 1969-
Cannabis is the most consumed illicit drug worldwide. Its principal psychoactive component, Δ9-tetrahydrocannabinol (THC), affects multiple brain functions, including cognitive performance, by modulating cannabinoid type-1 (CB1) receptors. These receptors are strongly enriched in presynaptic terminals, where they modulate neurotransmitter release. We analyzed, through a proteomic screening of hippocampal synaptosomal fractions, those proteins and pathways modulated 3 h after a single administration of an amnesic dose of THC (10 mg/kg, i.p.). Using an isobaric labeling approach, we identified 2040 proteins, 1911 of them previously reported in synaptic proteomes, confirming the synaptic content enrichment of the samples. Initial analysis revealed a significant alteration of 122 proteins, where 42 increased and 80 decreased their expression. Gene set enrichment analysis indicated an over-representation of mitochondrial associated functions and cellular metabolic processes. A second analysis focusing on extreme changes revealed 28 proteins with altered expression after THC treatment, 15 of them up-regulated and 13 down-regulated. Using a network topology-based scoring algorithm we identified those proteins in the mouse proteome with the greatest association to the 28 modulated proteins. This analysis pinpointed a significant alteration of the proteasome function, since top scoring proteins were related to the proteasome system (PS), a protein complex involved in ATP-dependent protein degradation. In this regard, we observed that THC decreases 20S proteasome chymotrypsin-like protease activity in the hippocampus. Our data describe for the first time the modulation of the PS in the hippocampus following THC administration under amnesic conditions that may contribute to an aberrant plasticity at synapses., This study was supported by Grants from the Ministerio de Economía, Innovación y Competitividad (MINECO) (#BFU2015-68568-P (MINECO/FEDER, UE) to A.O., #BFU2015-69717-P (MINECO/FEDER, UE) to RRV and AB, #RYC-2011-08391 to AB, #SAF2017-90664-REDT to RRV and AB, #SAF2014-59648-P and #SAF2017-84060-R to R.M.; a grant from the Instituto de Salud Carlos III (#RD16/0017/0020) to R.M.; Generalitat de Catalunya (2017SGR-669 to R.M. and 2017SGR1776 to RRV and AB) and ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M. Mass spectrometric analyses were performed at the CRG/UPF Proteomics Unit which is part of the of Proteored, PRB3 and is supported by grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF. Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO (#MDM-2014-0370); PLAN E (Plan Español para el Estímulo de la Economía y el Empleo); FEDER funding is also acknowledged
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Delta9-tetrahydrocannabinol modulates the proteasome system in the brain

  • Salgado Mendialdúa, Victòria
  • Aguirre Plans, Joaquim, 1993-
  • Guney, Emre
  • Reig-Viader, Rita
  • Maldonado, Rafael, 1961-
  • Bayés, Angels
  • Oliva Miguel, Baldomero
  • Ozaita Mintegui, Andrés, 1969-
Cannabis is the most consumed illicit drug worldwide. Its principal psychoactive component, Δ9-tetrahydrocannabinol (THC), affects multiple brain functions, including cognitive performance, by modulating cannabinoid type-1 (CB1) receptors. These receptors are strongly enriched in presynaptic terminals, where they modulate neurotransmitter release. We analyzed, through a proteomic screening of hippocampal synaptosomal fractions, those proteins and pathways modulated 3 h after a single administration of an amnesic dose of THC (10 mg/kg, i.p.). Using an isobaric labeling approach, we identified 2040 proteins, 1911 of them previously reported in synaptic proteomes, confirming the synaptic content enrichment of the samples. Initial analysis revealed a significant alteration of 122 proteins, where 42 increased and 80 decreased their expression. Gene set enrichment analysis indicated an over-representation of mitochondrial associated functions and cellular metabolic processes. A second analysis focusing on extreme changes revealed 28 proteins with altered expression after THC treatment, 15 of them up-regulated and 13 down-regulated. Using a network topology-based scoring algorithm we identified those proteins in the mouse proteome with the greatest association to the 28 modulated proteins. This analysis pinpointed a significant alteration of the proteasome function, since top scoring proteins were related to the proteasome system (PS), a protein complex involved in ATP-dependent protein degradation. In this regard, we observed that THC decreases 20S proteasome chymotrypsin-like protease activity in the hippocampus. Our data describe for the first time the modulation of the PS in the hippocampus following THC administration under amnesic conditions that may contribute to an aberrant plasticity at synapses., This study was supported by Grants from the Ministerio de Economía, Innovación y Competitividad (MINECO) (#BFU2015-68568-P (MINECO/FEDER, UE) to A.O., #BFU2015-69717-P (MINECO/FEDER, UE) to RRV and AB, #RYC-2011-08391 to AB, #SAF2017-90664-REDT to RRV and AB, #SAF2014-59648-P and #SAF2017-84060-R to R.M.; a grant from the Instituto de Salud Carlos III (#RD16/0017/0020) to R.M.; Generalitat de Catalunya (2017SGR-669 to R.M. and 2017SGR1776 to RRV and AB) and ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M. Mass spectrometric analyses were performed at the CRG/UPF Proteomics Unit which is part of the of Proteored, PRB3 and is supported by grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF. Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO (#MDM-2014-0370); PLAN E (Plan Español para el Estímulo de la Economía y el Empleo); FEDER funding is also acknowledged
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characterization of the TLR Family in Branchiostoma lanceolatum and Discovery of a Novel TLR22-Like Involved in dsRNA Recognition in Amphioxus

  • Ji, Jie|||0000-0002-3087-8370
  • Ramos-Vicente, David|||0000-0002-2730-0850
  • Navas-Pérez, Enrique
  • Herrera-Úbeda, Carlos
  • Lizcano de Vega, José Miguel|||0000-0002-3154-5383
  • García-Fernández, Jordi
  • Escrivà, Hector
  • Bayés, Àlex|||0000-0002-5265-6306
  • Roher Armentia, Nerea|||0000-0002-6659-4038
Toll-like receptors (TLRs) are important for raising innate immune responses in both invertebrates and vertebrates. Amphioxus belongs to an ancient chordate lineage which shares key features with vertebrates. The genomic research on TLR genes in Branchiostoma floridae and Branchiostoma belcheri reveals the expansion of TLRs in amphioxus. However, the repertoire of TLRs in Branchiostoma lanceolatum has not been studied and the functionality of amphioxus TLRs has not been reported. We have identified from transcriptomic data 30 new putative TLRs in B. lanceolatum and all of them are transcribed in adult amphioxus. Phylogenetic analysis showed that the repertoire of TLRs consists of both non-vertebrate and vertebrate-like TLRs. It also indicated a lineage-specific expansion in orthologous clusters of the vertebrate TLR11 family. We did not detect any representatives of the vertebrate TLR1, TLR3, TLR4, TLR5 and TLR7 families. To gain insight into these TLRs, we studied in depth a particular TLR highly similar to a B. belcheri gene annotated as bbtTLR1. The phylogenetic analysis of this novel BlTLR showed that it clusters with the vertebrate TLR11 family and it might be more related to TLR13 subfamily according to similar domain architecture. Transient and stable expression in HEK293 cells showed that the BlTLR localizes on the plasma membrane, but it did not respond to the most common mammalian TLR ligands. However, when the ectodomain of BlTLR is fused to the TIR domain of human TLR2, the chimeric protein could indeed induce NF-κB transactivation in response to the viral ligand Poly I:C, also indicating that in amphioxus, specific accessory proteins are needed for downstream activation. Based on the phylogenetic, subcellular localization and functional analysis, we propose that the novel BlTLR might be classified as an antiviral receptor sharing at least partly the functions performed by vertebrate TLR22. TLR22 is thought to be viral teleost-specific TLR but here we demonstrate that teleosts and amphioxus TLR22-like probably shared a common ancestor. Additional functional studies with other lancelet TLR genes will enrich our understanding of the immune response in amphioxus and will provide a unique perspective on the evolution of the immune system.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Metazoan evolution of glutamate receptors reveals unreported phylogenetic groups and divergent lineage-specific events

  • Ramos-Vicente, David|||0000-0002-2730-0850
  • Ji, Jie|||0000-0002-3087-8370
  • Gratacòs-Batlle, Esther
  • Gou Alsina, Gemma|||0000-0001-7438-2417
  • Reig-Viader, Rita|||0000-0002-6893-6177
  • Luís, Javier
  • Burguera, Demian
  • Navas-Pérez, Enrique
  • García-Fernández, Jordi
  • Fuentes-Prior, Pablo|||0000-0002-6618-3204
  • Escrivà, Hector
  • Roher Armentia, Nerea|||0000-0002-6659-4038
  • Soto, David
  • Bayés, Àlex|||0000-0002-5265-6306
Glutamate receptors are divided in two unrelated families: ionotropic (iGluR), driving synaptic transmission, and metabotropic (mGluR), which modulate synaptic strength. The present classification of GluRs is based on vertebrate proteins and has remained unchanged for over two decades. Here we report an exhaustive phylogenetic study of GluRs in metazoans. Importantly, we demonstrate that GluRs have followed different evolutionary histories in separated animal lineages. Our analysis reveals that the present organization of iGluRs into six classes does not capture the full complexity of their evolution. Instead, we propose an organization into four subfamilies and ten classes, four of which have never been previously described. Furthermore, we report a sister class to mGluR classes I-III, class IV. We show that many unreported proteins are expressed in the nervous system, and that new Epsilon receptors form functional ligand-gated ion channels. We propose an updated classification of glutamate receptors that includes our findings. Nerve cells or neurons communicate with each other by releasing specific molecules in the gap between them, the synapses. The sending neuron passes on messages through packets of chemicals called neurotransmitters, which are picked up by the receiving cell with the help of receptors on its surface. Neurons use different neurotransmitters to send different messages, but one of the most common ones is glutamate. There are two families of glutamate receptors: ionotropic receptors, which can open or close ion channels in response to neurotransmitters and control the transmission of a signal, and metabotropic receptors, which are linked to a specific protein and control the strength of signal. Our understanding of these two receptor families comes from animals with backbones, known as vertebrates. But the receptors themselves are ancient. We can trace the first family back as far as bacteria and the second back to single-celled organisms like amoebas. Vertebrates have six classes of ionotropic and three classes of metabotropic glutamate receptor. But other multi-celled animals also have these receptors, so this picture may not be complete. Here, Ramos-Vicente et al. mapped all major lineages of animals to reveal the evolutionary history of these receptors to find out if the receptor families became more complicated as brain power increased. The results showed that the glutamate receptors found in vertebrates are only a fraction of all the types that exist. In fact, before present-day animal groups emerged, the part of the genome that holds the ionotropic receptor genes duplicated three times. This formed four receptor subfamilies, and our ancestors had all of them. Across the animal kingdom, there are ten, not six, classes of ionotropic receptors and there is an extra class of metabotropic receptors. But only two subfamilies of ionotropic and three out of four metabotropic receptor classes are still present in vertebrates today. The current classification of glutamate receptors centers around vertebrates, ignoring other animals. But this new data could change that. A better knowledge of these new receptors could aid neuroscientists in better understanding the nervous system. And, using this technique to study other families of proteins could reveal more missing links in evolution.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evolution of complexity in the zebrafish synapse proteome

  • Bayés, Àlex|||0000-0002-5265-6306
  • Collins, Mark O.|||0000-0002-7656-4975
  • Reig-Viader, Rita|||0000-0002-6893-6177
  • Gou Alsina, Gemma|||0000-0001-7438-2417
  • Goulding, David
  • Izquierdo, Abril
  • Choudhary, Jyoti S.
  • Emes, Richard D.|||0000-0001-6855-5481
  • Grant, Seth G. N.
The proteome of human brain synapses is highly complex and is mutated in over 130 diseases. This complexity arose from two whole-genome duplications early in the vertebrate lineage. Zebrafish are used in modelling human diseases; however, its synapse proteome is uncharacterized, and whether the teleost-specific genome duplication (TSGD) influenced complexity is unknown. We report the characterization of the proteomes and ultrastructure of central synapses in zebrafish and analyse the importance of the TSGD. While the TSGD increases overall synapse proteome complexity, the postsynaptic density (PSD) proteome of zebrafish has lower complexity than mammals. A highly conserved set of ∼1,000 proteins is shared across vertebrates. PSD ultrastructural features are also conserved. Lineage-specific proteome differences indicate that vertebrate species evolved distinct synapse types and functions. The data sets are a resource for a wide range of studies and have important implications for the use of zebrafish in modelling human synaptic diseases. Systematic analysis of the zebrafish synapse proteome has been lacking. Here the authors characterize the ultrastructure of zebrafish synapse and compare the proteomes of postsynaptic density in zebrafish and mice, offering a resource for future studies using zebrafish to model diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Endogenous Syngap1 Alpha Splice Forms Promote Cognitive Function and Seizure Protection

  • Kilinc, Murat
  • Arora, Vineet
  • Creson, Thomas K.
  • Rojas, Camilo
  • Le, Aliza A.
  • Lauterborn, Julie
  • Wilkinson, Brent
  • Hartel, Nicolas
  • Graham, Nicholas
  • Reich, Adrian
  • Gou Alsina, Gemma|||0000-0001-7438-2417
  • Araki, Yoichi
  • Bayés, Àlex|||0000-0002-5265-6306
  • Coba, Marcelo P.
  • Lynch, Gary
  • Miller, Courtney A.
  • Rumbaugh, Gumbaugh
Loss-of-function variants in SYNGAP1 cause a developmental encephalopathy defined by cognitive impairment, autistic features, and epilepsy. SYNGAP1 splicing leads to expression of distinct functional protein isoforms. Splicing imparts multiple cellular functions of SynGAP proteins through coding of distinct C-terminal motifs. However, it remains unknown how these different splice sequences function in vivo to regulate neuronal function and behavior. Reduced expression of SynGAP-α1/2 C-terminal splice variants in mice caused severe phenotypes, including reduced survival, impaired learning, and reduced seizure latency. In contrast, upregulation of α1/2 expression improved learning and increased seizure latency. Mice expressing α1-specific mutations, which disrupted SynGAP cellular functions without altering protein expression, promoted seizure, disrupted synapse plasticity, and impaired learning. These findings demonstrate that endogenous SynGAP isoforms with α1/2 spliced sequences promote cognitive function and impart seizure protection. Regulation of SynGAP-α expression or function may be a viable therapeutic strategy to broadly improve cognitive function and mitigate seizure.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Synaptic proteomics as a means to identify the molecular basis of mental illness, Are we getting there?

  • Reig-Viader, Rita|||0000-0002-6893-6177
  • Sindreu, Carlos|||0000-0001-6730-8278
  • Bayés, Àlex|||0000-0002-5265-6306
Synapses are centrally involved in many brain disorders, particularly in psychiatric and neurodevelopmental ones. However, our current understanding of the proteomic alterations affecting synaptic performance in the majority of mental illnesses is limited. As a result, novel pharmacotherapies with improved neurological efficacy have been scarce over the past decades. The main goal of synaptic proteomics in the context of mental illnesses is to identify dysregulated molecular mechanisms underlying these conditions. Here we reviewed and performed a meta-analysis of previous neuroproteomic research to identify proteins that may be consistently dysregulated in one or several mental disorders. Notably, we found very few proteins reproducibly altered among independent experiments for any given condition or between conditions, indicating that we are still far from identifying key pathophysiological mechanisms of mental illness. We suggest that future research in the field will require higher levels of standardization and larger-scale experiments to address the challenge posed by biological and methodological variability. We strongly believe that more resources should be placed in this field as the need to identify the molecular roots of mental illnesses is highly pressing.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy

  • Ribeiro-Constante, Juliana
  • Tristán Noguero, Alba|||0000-0002-0170-9762
  • Martínez Calvo, Fernando Francisco
  • Ibañez-Mico, Salvador|||0000-0003-4582-6511
  • Peña Segura, José Luis
  • Ramos-Fernández, José Miguel
  • Moyano Chicano, María del Carmen
  • Camino León, Rafael
  • Soto Insuga, Víctor
  • González Alguacil, Elena
  • Valera Dávila, Carlos
  • Fernández-Jaén, Alberto
  • Plans, Laura
  • Camacho, Ana
  • Visa-Reñé, Nuria
  • Martin-Tamayo Blázquez, María del Pilar
  • Paredes-Carmona, Fernando
  • Marti-Carrera, Itxaso
  • Hernández-Fabián, Aránzazu
  • Tomas Davi, Meritxell
  • Casadesús, Mercè
  • Herraiz, Laura Cuesta
  • Pita, Patricia Fuentes
  • Bermejo González, Teresa
  • O'Callaghan, Maria del Mar|||0000-0002-1896-1622
  • Iglesias Santa Polonia, Federico Felipe
  • Cazorla, María Rosario
  • Ferrando Lucas, María Teresa
  • González-Meneses, Antonio
  • Sala-Coromina, Júlia|||0000-0001-5116-6316
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Lasa-Aranzasti, Amaia|||0000-0002-9136-5106
  • Cueto-González, Anna Mª|||0000-0001-7694-6124
  • Valera Párraga, Francisca
  • Campistol Plana, Jaume
  • Serrano, Mercedes|||0000-0002-2056-2428
  • Alonso, Xenia
  • Castillo Berges, Diego del|||0000-0003-1931-1266
  • Schwartz-Palleja, Marc
  • Illescas, Sofía
  • Ramírez Camacho, Alia
  • Sans Capdevila, Òscar|||0009-0004-9766-8716
  • García-Cazorla, Angels|||0000-0001-9853-688X
  • Bayés, Àlex|||0000-0002-5265-6306
  • Alonso-Colmenero, Itziar
SYNGAP1 haploinsufficiency results in a developmental and epileptic encephalopathy (DEE) causing generalized epilepsies accompanied by a spectrum of neurodevelopmental symptoms. Concerning interictal epileptiform discharges (IEDs) in electroencephalograms (EEG), potential biomarkers have been postulated, including changes in background activity, fixation-off sensitivity (FOS) or eye closure sensitivity (ECS). In this study we clinically evaluate a new cohort of 36 SYNGAP1-DEE individuals. Standardized questionnaires were employed to collect clinical, electroencephalographic and genetic data. We investigated electroencephalographic findings, focusing on the cortical distribution of interictal abnormalities and their changes with age. Among the 36 SYNGAP1-DEE cases 18 presented variants in the SYNGAP1 gene that had never been previously reported. The mean age of diagnosis was 8 years and 8 months, ranging from 2 to 17 years, with 55.9% being male. All subjects had global neurodevelopmental/language delay and behavioral abnormalities; 83.3% had moderate to profound intellectual disability (ID), 91.7% displayed autistic traits, 73% experienced sleep disorders and 86.1% suffered from epileptic seizures, mainly eyelid myoclonia with absences (55.3%). A total of 63 VEEGs were revised, observing a worsening of certain EEG findings with increasing age. A disorganized background was observed in all age ranges, yet this was more common among older cases. The main IEDs were bilateral synchronous and asynchronous posterior discharges, accounting for ≥50% in all age ranges. Generalized alterations with maximum amplitude in the anterior region showed as the second most frequent IED (≥15% in all age ranges) and were also more common with increasing age. Finally, diffuse fast activity was much more prevalent in cases with 6 years or older. To the best of our knowledge, this is the first study to analyze EEG features across different age groups, revealing an increase in interictal abnormalities over infancy and adolescence. Our findings suggest that SYNGAP1 haploinsufficiency has complex effects in human brain development, some of which might unravel at different developmental stages. Furthermore, they highlight the potential of baseline EEG to identify candidate biomarkers and the importance of natural history studies to develop specialized therapies and clinical trials.